Impact of BACIS Program on Quality of Care

2021 ◽  
pp. 125-135
Keyword(s):  
Quality Of Care ◽  
Clinical Practice ◽  
Decision Support ◽  
Maternal Health ◽  
Clinical Practice Guideline ◽  
Practice Guideline ◽  
Support Systems ◽  
Standards Of Care ◽  
Qualitative Review

This chapter presents the methodology for measuring the system's impact on the quality of care. The system's impact on the quality of care was measured through a compliance review using the standards of care set in the maternal health guidelines. In the framework for development of clinical practice guideline-based decision support systems, the compliance review is part of the section on evaluation. The compliance review addresses the following objectives: measurement of compliance with processes of care at the study clinic before introduction of the BACIS program, measurement of improvements in compliance after the introduction of the BACIS program, and a qualitative review undertaken in order to understand the reasons for non-compliance.

scholarly journals Plain Language Summary: Hoarseness (Dysphonia)

2018 ◽  
Vol 158 (3) ◽  
pp. 427-431 ◽  
Author(s):  
Helene J. Krouse ◽  
Charles (Charlie) W. Reavis ◽  
Robert J. Stachler ◽  
David O. Francis ◽  
Sarah O’Connor
Keyword(s):  
Quality Of Care ◽  
Clinical Practice ◽  
Clinical Practice Guideline ◽  
Practice Guideline ◽  
Age Groups ◽  
Evidence Based ◽  
Plain Language ◽  
Evidence Based Guideline

This plain language summary for patients serves as an overview in explaining hoarseness (dysphonia). The summary applies to patients in all age groups and is based on the 2018 “Clinical Practice Guideline: Hoarseness (Dysphonia) (Update).” The evidence-based guideline includes research to support more effective identification and management of patients with hoarseness (dysphonia). The primary purpose of the guideline is to improve the quality of care for patients with hoarseness (dysphonia) based on current best evidence.

Design and Development of BACIS Program

2021 ◽  
pp. 104-113
Keyword(s):  
Clinical Practice ◽  
Decision Support ◽  
Clinical Practice Guideline ◽  
Practice Guideline ◽  
Support Systems ◽  
System Development ◽  
Design And Development ◽  
Health Practitioners ◽  
Study Participants ◽  
Document Review

In this chapter, the framework from Chapter 6 on design and development of clinical practice guideline-based decision support systems is used to review the design and development of the BACIS program. The data for carrying out the review of the BACIS program is drawn from three main sources. These are interviews of the health practitioners participating in the BACIS program study, a document review, as well as from observations made by the author during the study in his engagement with study participants during the stages of system development and piloting. In the evaluation, a review of requirements analysis is carried out, as per the framework elaborated in Chapter 6. Then a review of the systems features is also carried out after it.

Quality of 2019 American optometric association clinical practice guideline for diabetic eye care

2020 ◽  
Vol 41 (1) ◽  
pp. 165-170
Author(s):  
Rajendra Gyawali ◽  
Melinda Toomey ◽  
Fiona Stapleton ◽  
Lisa Dillon ◽  
Barbara Zangerl ◽  
...  
Keyword(s):  
Clinical Practice ◽  
Clinical Practice Guideline ◽  
Practice Guideline ◽  
Eye Care

scholarly journals Development and Validation of a Tool to Assess the Quality of Clinical Practice Guideline Recommendations

2020 ◽  
Vol 3 (5) ◽  
pp. e205535 ◽  
Author(s):  
Melissa C. Brouwers ◽  
Karen Spithoff ◽  
Kate Kerkvliet ◽  
Pablo Alonso-Coello ◽  
Jako Burgers ◽  
...  
Keyword(s):  
Clinical Practice ◽  
Clinical Practice Guideline ◽  
Practice Guideline ◽  
Development And Validation

scholarly journals Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of urothelial cancer

2021 ◽  
Vol 9 (7) ◽  
pp. e002552
Author(s):  
Matthew D Galsky ◽  
Arjun V Balar ◽  
Peter C Black ◽  
Matthew T Campbell ◽  
Gail S Dykstra ◽  
...  
Keyword(s):  
Clinical Practice ◽  
Patient Outcomes ◽  
Clinical Practice Guideline ◽  
Practice Guideline ◽  
Urothelial Cancer ◽  
Diagnostic Testing ◽  
Care Providers ◽  
Immunotherapy Of Cancer ◽  
Selection Of

A number of immunotherapies have been developed and adopted for the treatment of urothelial cancer (encompassing cancers arising from the bladder, urethra, or renal pelvis). For these immunotherapies to positively impact patient outcomes, optimal selection of agents and treatment scheduling, especially in conjunction with existing treatment paradigms, is paramount. Immunotherapies also warrant specific and unique considerations regarding patient management, emphasizing both the prompt identification and treatment of potential toxicities. In order to address these issues, the Society for Immunotherapy of Cancer (SITC) convened a panel of experts in the field of immunotherapy for urothelial cancer. The expert panel developed this clinical practice guideline (CPG) to inform healthcare professionals on important aspects of immunotherapeutic treatment for urothelial cancer, including diagnostic testing, treatment planning, immune-related adverse events (irAEs), and patient quality of life (QOL) considerations. The evidence- and consensus-based recommendations in this CPG are intended to give guidance to cancer care providers treating patients with urothelial cancer.

Sign in / Sign up

Export Citation Format

Share Document